Keyword: return on investment

This Finance survey examines (a) Establishing a domestic sovereign wealth fund to invest in domestic infrastructure, emerging technologies, and/or strategic sectors would bring substantial benefits to the US economy over a ten-year horizon; (b) For the US, establishing a sovereign wealth fund would be substantially better for citizens relative to reducing public debt burdens

This US survey examines (a) Establishing a domestic sovereign wealth fund to invest in infrastructure, emerging technologies, and/or strategic sectors would bring substantial benefits to the US economy over a ten-year horizon; (b) The typical advanced economy could substantially boost growth by establishing a sovereign wealth fund to invest in infrastructure, emerging technologies, and/or strategic sectors; (c) For a typical advanced economy, establishing a sovereign wealth fund would be substantially better for citizens relative to paying down the debt as a use for excess revenue

This Finance survey examines (a) Letting publicly traded firms report earnings annually rather than quarterly would lead their executives to place more weight on long-term issues in their investments and other decisions; (b) A switch from quarterly to annual earnings reports would, on net, benefit shareholders

This week's European Economic Experts Panel statements: A) Removing intellectual property protections on Covid-19 vaccines would substantially improve availability of the vaccines in developing countries. B) Removing intellectual property protections on Covid-19 vaccines would have a negative impact on vaccine development efforts for future variants of SARS-CoV-2 or for the next pandemic. C) Without an international agreement that facilitates vaccine trade, countries’ incentives to limit exports of vaccines and/or key production inputs are likely to prolong the adverse effects of the pandemic in advanced countries.

This week's US Economic Experts Panel statements: A) Removing intellectual property protections on Covid-19 vaccines would substantially improve availability of the vaccines in developing countries. B) Removing intellectual property protections on Covid-19 vaccines would have a negative impact on vaccine development efforts for future variants of SARS-CoV-2 or for the next pandemic. C) Without an international agreement that facilitates vaccine trade, countries’ incentives to limit exports of vaccines and/or key production inputs are likely to prolong the adverse effects of the pandemic in advanced countries.

This week’s IGM European Economic Experts Panel statements:   A) Given the social and regulatory pressures to keep prices down for drugs and vaccines to treat Covid-19, the financial incentives for pharmaceutical companies to invest in such products are below the value of the investment to society. B) Government commitments to pay developers and manufacturers above average costs for an effective vaccine or drug treatments for Covid-19 would accelerate production. C) Given the positive externalities from vaccination, an effective Covid-19 vaccine should have priority in public healthcare funding even in countries where other diseases cause more death and disability.  

This week’s IGM Economic Experts Panel statements: A) Given the social and regulatory pressures to keep prices down for drugs and vaccines to treat Covid-19, the financial incentives for pharmaceutical companies to invest in such products are below the value of the investment to society. B) Government commitments to pay developers and manufacturers above average costs for an effective vaccine or drug treatments for Covid-19 would accelerate production. C) Given the positive externalities from vaccination, an effective Covid-19 vaccine should be mandatory for every US resident (except those with health exceptions, such as infants and people with compromised immunity) with the cost covered by the federal government.

This week’s IGM European Economic Experts Panel statements: A) Europeans would benefit more from an extra €1 billion of public R&D spent through existing (public) channels than from an extra €1 billion of private R&D spent through existing (private) channels, all else equal. B) Europeans would benefit more from an extra €1 billion of public medical research spent through existing (public) channels than from an extra €1 billion of private medical research spent through existing (private) channels, all else equal.

This week's IGM European Economic Experts Panel statements: A) Letting publicly traded European firms report earnings annually rather than quarterly would lead their executives to place more weight on long-term issues in their investments and other decisions. B) A switch from quarterly to annual earnings reports would, on net, benefit shareholders of European firms.